These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38550169)

  • 1. Retracted: Studying the Role and Molecular Mechanisms of
    International BR
    Biomed Res Int; 2024; 2024():9760191. PubMed ID: 38550169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying the Role and Molecular Mechanisms of
    Shi Y; Mo X; Hong S; Li T; Chen B; Chen G
    Biomed Res Int; 2020; 2020():4965670. PubMed ID: 33204699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9817406. PubMed ID: 37564537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
    Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
    Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
    International BR
    Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma.
    Shan Y; Li P
    Yonsei Med J; 2019 Sep; 60(9):842-853. PubMed ID: 31433582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9754751. PubMed ID: 38074348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction].
    Onco Targets Ther; 2022; 15():871-872. PubMed ID: 36033902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies.
    BioMed Research International
    Biomed Res Int; 2018; 2018():4560161. PubMed ID: 29854758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Perspectives of Molecular Therapy-Targeted Mitochondrial Fission in Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9856592. PubMed ID: 38230168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9782763. PubMed ID: 37503422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9783892. PubMed ID: 37772007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
    International BR
    Biomed Res Int; 2021; 2021():1916343. PubMed ID: 33728325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma
    Wang X; Wang M; Li XY; Li J; Zhao DP
    Oncol Lett; 2023 Aug; 26(2):345. PubMed ID: 37427345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9808276. PubMed ID: 37503372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
    International BR
    Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9853278. PubMed ID: 37266250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.